The National Institutes of Health (NIH) has awarded the Rutgers Institute for Translational Medicine and Science $39,673,786 over seven years to build and improve upon infrastructure that promotes clinical and translational science through the New Jersey Alliance for Clinical and Translational Science (NJ ACTS).

The Rutgers Institute for Translational Medicine and Science will receive the federal funding (grant number UM1TR004789) from the National Center for Advancing Translational Sciences over the next seven years to promote translational science, which uses discoveries made in the laboratory, clinic and community to create interventions that improve the health of individuals and populations – from diagnostics and therapeutics to medical procedures and behavioral health interventions.

The funding, which became active May 1, will enable NJ ACTS to expand and improve its statewide program that was created in 2019 to quickly translate research discoveries into patient care. To read the full story.